Posted by Michael Wonder on 07 Dec 2022
US backs delay to decision on COVID patent waiver extension
6 December 2022 - The United States on Tuesday urged delaying a decision on whether to waive patent protection for COVID-19 treatments and tests, as demanded by many developing countries, a move branded "pathetic" by a leading campaign group.
World Trade Organisation members agreed in June a partial waiver of intellectual property rights for COVID-19 vaccines, with an understanding that they should consider within six months extending this to therapeutics and diagnostics.
